drugset
Drugs / Killed Bivalent (O1 and O139) whole cell oral cholera vaccine
last change Aug 2013 re-read 3 minutes ago

Killed Bivalent (O1 and O139) whole cell oral cholera vaccine

Vaccine

Developed for
cholera
Investigated by
Armauer Hansen Research Institute, Ethiopia · International Vaccine Institute · Ministry of Health, Ethiopia · Shantha Biotechnics Limited

Trials 1

today NCT01524640 · Ph 4
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01524640 Dec 2012 → Aug 2013 cholera International Vaccine Institute Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Killed Bivalent (O1 and O139) whole cell oral cholera vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01524640 ↗
Modality Vaccine “killed oral cholera vaccine” NCT01524640 ↗
Route Oral “1.5 ml single dose oral administration on day 0 and day 14” NCT01524640 ↗